June 2021, В настоящей ситуации распространяется неисчислимое количество информации о COVID-19, причем некоторые
уже говорят о “инфодемии”. Очень трудно найти информаци...ю, содержащую научно обоснованные рекомендации
из надежных источников. Поэтому MEDBOX создал Инструментарий COVID-19 (www.covid19box.org), сборник
проверенных, профессиональных и актуальных ресурсов на тему COVID-19. В нем содержатся руководства,
материалы для информации, образования и коммуникации, включая видео и онлайн-курсы, планы действий
и многое другое, собранное на одном сайте. Кроме того, в нем размещены ссылки на другие полезные
ресурсные платформы, содержащие достоверную информацию. Здесь вы найдете наиболее важные документы,
включенные в Инструментарий COVID-19.
more
Update, 23 de junio de 2022
временные рекомендации от 8 января 2021 г.
Available in Arabic, Chinese, English, French, Russian and Spanish here: https://apps.who.int/iris/handle/10665/338484
Mortality statistics are fundamental to public health decision making. Mortality varies by time and location, and its measurement is affected by well known biases that have been exacerbated during the COVID-19 pandemic. This paper aims to estimate excess mortality from ...the COVID-19 pandemic in 191 countries and territories, and 252 subnational units for selected countries, from Jan 1, 2020, to Dec 31, 2021.
The Lancet. 10 March 2022. doi: 10.1016/S0140-6736(21)02796-3.
more
The webpage from the Pan American Health Organization (PAHO) discusses the heightened risk that individuals with noncommunicable diseases (NCDs)—such as cardiovascular diseases, diabetes, and cancer—face regarding severe illness and mortality from COVID-19. It emphasizes the necessity of informi...ng the public about these health risks and adapting healthcare services to ensure the continuity of essential NCD care during the pandemic. The page provides information and guidance for healthcare providers and the public on managing NCDs in the context of COVID-19, highlighting the importance of addressing NCDs and their risk factors with a medium- to long-term perspective.
more
La prévalence de la covid -19 chez la femme enceinte et les accouchées semble être faible. Elles étaient asymptomatiques et le pronostic maternel était satisfaisant. Néanmoins, le risque de for.pdf
The global impact of COVID-19 has been profound, and the public health threat it represents is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic. Here we present the results of epidemiological modelling which has informed policymaking in the UK and other countries i...n recent weeks.
more
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
The advice is presented in a Q&A format, addressing the following questions:
Are pregnant women at higher risk from COVID-19?
I’m pregnant. How can I protect myself against COVID-19?
Should pregnant women be tested for COVID-19?
Can COVID-19 be passed from a woman to her unborn or newborn ba...by?
What care should be available during pregnancy and childbirth?
Do pregnant women with suspected or confirmed COVID-19 need to give birth by caesarean section?
Can women with COVID-19 breastfeed?
Can I touch and hold my newborn baby if I have COVID-19?
I have COVID-19 and am too unwell to breastfeed my baby directly. What can I do?
more
Evolving Patterns of Worldwide Distribution as of 14thFebruary 2021
the Principles for Dose-Sharing provide a framework for higher-income economies to make additional volumes secured via bilateral deals available through the Facility primarily to AMC participants, on an equitable basis. These principles outline that such doses must be safe and effective, available a...s early as possible and should be available in substantive volumes as early as possible in 2021 to enable rapid and flexible deployment by the Facility – supporting the overall goal of equitable access.
18 Dec 2020
more
Find out how many vaccine doses have been given in your country using WHO’s COVID-19 dashboard
As a Frontline Health Care Worker or a Vaccinator, you need to counsel pregnant women about the availability, value and precautions regarding the COVID-19 vaccine. This note provides you with the information that you need to educate and support pregnant women so that they can make an informed decisi...on about getting the COVID-19 vaccine. The note is structured in the form of questions-answers to make it easier for you to inform pregnant women and their families about the most important issues related to COVID-19 vaccination in pregnant women.
more
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This... policy brief was developed by the WHO Access to COVID-19 Tools (ACT) Accelerator Ethics & Governance Working Group, to provide guidance for researchers, sponsors, regulators, research ethics committees, and policy-makers, on these and related issues.
more
BMJ Global Health2020;5:e002786. doi:10.1136/bmjgh-2020-002786
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...ussian | Spanish | Portuguese
A follow-up phase to expand coverage to other populations. If severe supply constraints persist, a weighted allocation approach would be adopted, taking account of a country’s COVID threat and vulnerability.
The document is a final working document and may be adjusted in the future as new information about the vaccines and the epidemiology of COVID-19 becomes available.
more